Novartis ANZ
在场
是其中之一......
- Forbes Global 2000 (#99);
- Fortune 500 Europe (#62);
- Global Fortune 500 (#263);
- Stoxx 600;
- Swiss market index;
- TOB Iconic 10,000.
Novartis 是一家在股票代码 NOVN (CH) 下上市的公司。
Novartis 在 38 个国家有直接业务。Novartis 拥有 73家子公司，其中包括 Advanced Accelerator Applications、Alcon 和 Alcon ANZ。
他们在：
涉及Novartis的并购和融资。
- Novartis has announced the acquisition of Chinook Therapeutics (公布2023八月14号).
- Novartis has announced the acquisition of DTx Pharma (公布2023七月18号).
- Novartis has announced the acquisition of Chinook Therapeutics (公布2023六月15号).
高管
查看带有其 2 名主要高管的组织结构图
Novartis ANZ 搜索最多的简介
高管在Novartis变化
- Joerg Reinhardt, Chairman of the Board, 将于 20253月 退休 (新闻发布的2024四月25号).
创建提醒
跟踪 Novartis ANZ 的高管变动
药店
Novartis 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
Novartis ANZ 的最新新闻稿
- News Archive | Novartis Australia
- News Archive | Novartis Australia
- News Archive | Novartis Australia
- News | Novartis
- News Archive | Novartis Australia
- Novartis, Telstra Health and Monash University join forces to tackle Australia’s number one killer – heart disease
- Novartis, Telstra Health and Monash University join forces to tackle Australia’s number one killer – heart disease | Novartis Australia
- Australia’s first gene therapy for babies born with spinal muscular atrophy (SMA), Zolgensma®, becomes available on the PBS | Novartis Australia
- Industry and clinical collaboration delivers screening pilot for heart wellness – yet more awareness and access needed to address Australia’s biggest killer | Novartis Australia
- The Australian Bushfires | Novartis Australia
- View more press releases Close
关于 Novartis ANZ 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Richard Tew 
